IFG Advisory’s AstraZeneca AZN Stock Holding History

IFG Advisory’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$426K	Sell	2,639 -18	-0.7%	-$3K	0.01%	664
2026 Q2	$504K	Buy	+2,657	New	+$500K	0.02%	606
2018 Q4	–	Sell	-3,722	Closed	-$294K	–	319
2018 Q3	$294K	Sell	3,722 -432	-10%	-$32.7K	0.06%	299
2018 Q2	$291K	Sell	4,154 -21	-0.5%	-$1.51K	0.06%	275
2018 Q1	$291K	Sell	4,175 -993	-19%	-$68.8K	0.06%	274
2017 Q4	$358K	Buy	+5,168	New	+$349K	0.08%	231

Other funds holding AZN

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

LBP AM Paris, France $11.2B AUM 34.48% 1-Year Est. Return

M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

IFG Advisory's AZN Position: Q3 2026 in Review

IFG Advisory reduced its AstraZeneca (AZN) stake by 0.68% in Q3 2026, selling an estimated $3K and leaving 2,639 shares worth $426K. The position accounts for 0.01% of the portfolio, ranked #664.

IFG Advisory first reported a position in AZN in Q4 2017 and has held it in 6 quarters since. The position peaked at $504K in Q2 2026. 844 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

IFG Advisory held 2,639 shares of AstraZeneca worth $426K as of Q3 2026.
IFG Advisory sold 18 AstraZeneca shares in Q3 2026, an estimated $3K.
AstraZeneca made up 0.01% of IFG Advisory's portfolio in Q3 2026, its #664 holding.
IFG Advisory first reported a position in AstraZeneca in Q4 2017 and has held it in 6 quarters since.
IFG Advisory's AstraZeneca position peaked at $504K in Q2 2026.
844 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on IFG Advisory's 13F filing for Q3 2026, filed 9 Nov 2026.